Anthrax

Background

  • Gram positive rod, Bacillus anthracis, which is capable of surviving inhospitable condition through the formation of endospores. tough spores
  • Incubation period is 10 days with no ability for human to human transmission and therefore, no need for respiratory isolation
    • Though human to human transmission does not occur, potential harbors of spores (patient clothes) need to be isolated and decontaminated with 10% bleach[1]
  • In general there is cutaneous, inhalational, and gastrointesinal anthrax.

Inhalational (5%)

  • Biphasic course

Prodrome Period

Acute phase

Cutaneous (95%)

Cutaneous anthrax
  • The disease will start as an area of erythema and edema and progress to a vesicle which ruptures forming a central black eschar
  • Total course of lesion evolution occurs over 1 week

Gastrointestinal

Differential Diagnosis

Cutaneous (painless)

  • Ecthyma gangrenosum
  • Rat-bite fever (Streptobacillus monilifomis and Spirillum minus)
  • Ulceroglandular tularemia
  • Plague
  • Glanders (Pseudomonas peudomallei)
  • Rickettsial pox (Rickettsia akari)
  • Orf (parapox virus)
  • Staph lymphadenitis
  • TB
  • Leprosy
  • Buruli ulcer (Mycobact ulcerans)

Inhalational

Lower Respiratory Zoonotic Infections

Bioterrorism Agents[4]

Category A

Category B

  • Ricin
  • Brucellosis
  • Epsilon toxin
  • Psittacosis
  • Q Fever
  • Staph enterotoxin B
  • Typhus
  • Glanders
  • Melioidosis
  • Food safety threats
  • Water safety threats
  • Viral encephalitis

Category C

Evaluation

  • CXR/CT
    • Widened mediastinum representing hemorrhagic mediastinitis
    • Infiltrate, pleural effusion
    • Hyperdense mediastinal lymphadenopathy

Management

Contact CDC Emergency Hotline 1-707-488-7100 for all suspected bioterrorism cases

Postexposure Prophylaxis

Patient should be vaccinated at day #0, #14, #28

Cutaneous Anthrax (not systemically ill)

  • Ciprofloxacin 500mg PO q12hrs x 60 days
  • Doxycycline 100mg PO q12hrs x 60 days

Inhalation or Cutaneous with systemic illness

Pediatric Postexpsoure Prophylaxis

Pediatric Cutaneous Anthrax (not ill)

  • Same as post exposure dosing and duration

Pediatric Inhalational or Cutaneous (systemically ill

Disposition

  • Admit

See Also

References

  1. Heninger SJ et al. Decontamination of Bacillus anthracis Spores: Evaluation of Various Disinfectants. Appl Biosaf. 2009 Jan 1; 14(1): 7–10.
  2. Medscape: Anthrax
  3. CDC. Gastrointestinal anthrax after an animal-hide drumming event - New Hampshire and Massachusetts, 2009. MMWR Morb Mortal Wkly Rep. 2010 Jul 23;59(28):872-7. http://www.ncbi.nlm.nih.gov/pubmed/20651643
  4. https://www.niaid.nih.gov/topics/biodefenserelated/biodefense/pages/cata.aspx Accessed 02/26/16
This article is issued from Wikem. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.